US-China Rivalry Expands to Biotech; Lawmakers Raise Alarm

FILE - In this photo released by China's Xinhua News Agency, staff members work in an inflatable COVID-19 testing lab provided by Chinese biotech company BGI Genomics, a subsidiary of BGI Group, in Beijing, June 23, 2020. FILE - Chairman Rep. Mike Gallagher listens during a hearing of a special House committee dedicated to countering China, on Capitol Hill in Washington, Feb. 28, 2023.

U.S. lawmakers are raising alarms about what they see as America's failure to compete with China in biotechnology, warning of the risks to U.S. national security and commercial interests. But as the two countries' rivalry expands into the biotech industry, some say that shutting out Chinese companies would only hurt the U.S.